0 CHECKOUT

Supplement 29 - Pharmaceutical and Medical Device Combination Products

  • ID: 1477239
  • January 2011
  • Region: Global
  • Euromed Communications

Combination products represent an increasingly important area of pharmaceutical development. It is estimated that almost 30% of the pharmaceutical industry research and development spend is currently allocated to such products. These combinations may include drug/device, device/drug and companion diagnostics. Only 15 years ago the term combination product would have automatically referred to a combination of two or more pharmaceutical substances. Today the term is widely understood to refer to the new type of combination of a medical device and a pharmaceutical.

For those working in clinical development, it is important to understand the approach and the different regulatory regimes that influence the development of such entities.

Note: Product cover images may vary from those shown

David Jeffreys, senior vice president of Eisai Europe

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: A printed copy of the report will be shipped to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S